Psilocybin therapy, once relegated to the fringes of medicine, is now operating legally in three U.S. states — and dozens more are watching closely.
Oregon and Colorado currently run the nation’s only fully regulated adult-access programs, while New Mexico is racing to see its first patients by the end of 2026 under a new medical psilocybin law. Meanwhile, more than 26 states are weighing legislation of their own, according to a detailed state-by-state breakdown from Psychedelic Beacon.
Federal policy is shifting too. An executive order this year has pushed the FDA to speed up review of psychedelic treatments for serious mental health conditions — though psilocybin remains a Schedule I substance nationally, with no legalization date in sight.
The patchwork is growing fast. Whether it becomes a coherent national policy is still an open question.